PMID- 31800372 OWN - NLM STAT- MEDLINE DCOM- 20200731 LR - 20200731 IS - 1557-8976 (Electronic) IS - 0882-8245 (Linking) VI - 32 IP - 10 DP - 2019 Dec TI - Association of HLA-A, -B, DRB, and DQB Alleles with Persistent HPV-16 Infection in Women from Tamil Nadu, India. PG - 430-441 LID - 10.1089/vim.2019.0094 [doi] AB - Women with persistent human papillomavirus (HPV) infections have a high risk of developing cervical cancer (CaCx). HPV-16 alone accounts for more than 60% of CaCx worldwide. Most of the HPV infections are transient and only a subset of women develop persistent HPV-16 infection. Many studies have shown associations of different human leukocyte antigen (HLA) alleles with HPV-mediated CaCx, but there are only a few studies globally that relate to persistent HPV-16 infection. Furthermore, such studies from India are sparse. Hence, we investigated the association of HLA-A, B, DRB, and DQB alleles with persistent HPV-16 infection and HPV-16-positive CaCx in south India (Tamil Nadu). HPV-16 persistent infection was observed in 7% of normal women. A total of 50 women with HPV-16-positive CaCx, 21 women with HPV-16 persistent infection, and 74 HPV-16-negative normal women were recruited for this study. Low-resolution typing of HLA-A, B, DRB, and DQB alleles was performed. HLA-B*44 and DRB1*07 showed a significant association with persistent HPV-16 infection (odds ratio, p-value = 26.3, 0.03 and 4.7, 0.01, respectively). HLA-B*27 and DRB1*12 were significantly associated with both HPV-16(+) CaCx and persistent HPV-16 infection (23.8, 0.03; 52.9, 0.01; 9.8, 0.0009; and 13.8, 0.009; respectively). HLA-B*15 showed a negative association with HPV-16-positive CaCx (0.1, 0.01), whereas DRB1*04 exhibited protection to both HPV-16-positive CaCx and persistent HPV-16 infection (0.3, 0.0001 and 0.1, 0.0002, respectively). Thus, we show HLA allelic association with HPV-16 infection in Tamil Nadu. Larger studies on high-resolution HLA typing coupled with HPV-16 genome diversity will offer further insights into host/pathogen genome coevolution. FAU - Bhaskaran, Muthumeenakshi AU - Bhaskaran M AD - Human Genomics Laboratory, Centre for Research in Infectious Disease (CRID), School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, India. FAU - Murali, Sree Varshini AU - Murali SV AD - Human Genomics Laboratory, Centre for Research in Infectious Disease (CRID), School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, India. FAU - Rajaram, Barathi AU - Rajaram B AD - Human Genomics Laboratory, Centre for Research in Infectious Disease (CRID), School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, India. FAU - Krishnasamy, Sundar AU - Krishnasamy S AD - Human Genomics Laboratory, Centre for Research in Infectious Disease (CRID), School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, India. FAU - Devasena, C S AU - Devasena CS AD - Department of Obstetrics and Gynaecology, Kovai Medical Centre and Hospital, Coimbatore, India. FAU - Pathak, Atima AU - Pathak A AD - Department of Obstetrics and Gynaecology, Kovai Medical Centre and Hospital, Coimbatore, India. FAU - Ravi, Vidhya AU - Ravi V AD - Department of Obstetrics and Gynaecology, K.A.P. Viswanatham, Government Medical College, Tiruchirapalli, India. FAU - Swaminathan, Krishnan AU - Swaminathan K AD - Department of Endocrinology, Kovai Medical Centre and Hospital and Research Foundation, Coimbatore, India. FAU - Ayyappa, Ashok AU - Ayyappa A AD - Human Genomics Laboratory, Centre for Research in Infectious Disease (CRID), School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, India. FAU - Vedhantham, Srinivasan AU - Vedhantham S AD - Division of R&D, MedGenome Labs Ltd., Bengaluru, India. FAU - Seshachalam, Arun AU - Seshachalam A AD - Department of Medical Oncology, GVN Hospital Ltd., Tiruchirapalli, India. FAU - ArunKumar, GaneshPrasad AU - ArunKumar G AD - Human Genomics Laboratory, Centre for Research in Infectious Disease (CRID), School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, India. LA - eng PT - Journal Article PT - Observational Study PT - Research Support, Non-U.S. Gov't DEP - 20191203 PL - United States TA - Viral Immunol JT - Viral immunology JID - 8801552 RN - 0 (DNA, Viral) RN - 0 (HLA-D Antigens) RN - 0 (Histocompatibility Antigens Class I) SB - IM MH - Adult MH - Alleles MH - Case-Control Studies MH - Cervix Uteri/immunology/virology MH - DNA, Viral/isolation & purification MH - Female MH - Genetic Predisposition to Disease MH - HLA-D Antigens/*genetics/immunology MH - Haplotypes/immunology MH - Histocompatibility Antigens Class I/*genetics/immunology MH - Host-Pathogen Interactions/genetics/immunology MH - Human papillomavirus 16/genetics/*immunology/isolation & purification MH - Humans MH - India MH - Middle Aged MH - Papillomavirus Infections/*genetics/immunology/virology MH - Polymorphism, Genetic MH - Uterine Cervical Neoplasms/*genetics/immunology/virology MH - Young Adult OTO - NOTNLM OT - HLA OT - HPV-16 OT - association studies OT - cervical cancer OT - persistent infection EDAT- 2019/12/05 06:00 MHDA- 2020/08/01 06:00 CRDT- 2019/12/05 06:00 PHST- 2019/12/05 06:00 [pubmed] PHST- 2020/08/01 06:00 [medline] PHST- 2019/12/05 06:00 [entrez] AID - 10.1089/vim.2019.0094 [doi] PST - ppublish SO - Viral Immunol. 2019 Dec;32(10):430-441. doi: 10.1089/vim.2019.0094. Epub 2019 Dec 3.